The ongoing trial is a small phase I in Maryland and Washington DC. AGT is not involved in the recruitment of patients for the trial, which is standard procedure in human trials, so you would need to be in touch with those hospitals to be considered for the study. It is likely that the patients will be recruited by the trial sites locally. You can stay up to date on current and future trials at clinicaltrials.gov (look up "American Gene Technologies" to find our open studies or click here).
If the upcoming study works as well as we hope, we will start additional (larger) studies immediately and press forward as quickly as possible to bring our drug to the market. We are passionate in our desire to make a difference to HIV+ individuals to help them live their lives free from the effects of HIV with as little inconvenience and reduction in quality-of-life as possible from treatments. It is our hope that our cell therapy may be able to give HIV+ individuals the ability to control their viremia without ongoing regular ART treatment. We are "swinging for the fences" with our attempt to develop a functional cure for HIV. Only human trials will give us a solid indication of whether we are on track to achieve our goal.